| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |